The Commission has published the REACH Review study assessing overlaps between REACH and other relevant EU legislation. It provides 38 findings with recommendations for action. It recommends amendments to legislation, both to REACH and sectoral legislation, as well as non-legislative options, such as the development of guidance documents or Commission recommendations.

The report suggests setting up a database that would serve as an inventory of all restrictions in place for particular substances as well as revising legislation to remove duplications and inconsistencies.

The report notes that for substances exempted from all or part of the REACH registration, including those used in medicinal products and cosmetics or those registered as plant protection or biocidal products, resulted in gaps in risk assessment. This is because the manufacturing, formulation and waste management stages are not covered by the risk assessment performed under sectoral legislation.

Click here for more information about the report.